Company dossier
Beta Drugs
NSE:BETA · ISIN INE351Y01019
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Beta Drugs
Ownership
Shareholding pattern
Exchange XBRLOwnership by reported class
| Holder class | 30 Jun 26 | 25 May 26 | 31 Mar 26 | 31 Dec 25 | 30 Sept 25 | 30 Jun 25 |
|---|---|---|---|---|---|---|
| Promoter group | 59.10% | 59.10% | 64.63% | 64.90% | 66.73% | 66.73% |
| Public | 40.90% | 40.90% | 35.37% | 35.10% | 33.27% | 33.27% |
| Employee trust | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Next ownership layer
Planned enrichmentHolder-level detail
Mutual funds, foreign institutions, insurers, promoter entities, pledges and beneficial-owner changes will be added from detailed shareholding facts. This summary does not infer those classes.